Nova Scotia's new chief medical officer of health to take over from Dr. Robert Strang in January - PNI Atlantic News
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Skip to Content Home Filter by region Nova Scotia Halifax Local Sports Local Business Local Opinion Annapolis Valley Truro Tri-County New Glasgow South Shore Antigonish Cape Breton Prince Edward Island Summerside Newfoundland & Labrador News Canada Health World Opinion Editorial Cartoons Business Local Business Sports Local Sports Baseball Basketball Football Hockey Entertainment & Life Food Homes Savings Special Sections Lives Told Tails Told Shopping Essentials Deals Entertainment & Hobbies Gift Guide Home Living Kitchen & Dining Outdoor Living Personal Care Style & Beauty Tech Travel Guide PNI Atlantic Store ePaper Puzzmo Newsletters Travel Business Ads Obituaries Classifieds Jobs Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Profile Settings My Subscriptions Newsletters Customer Service FAQ News Opinion Business Sports Entertainment & Life Special Sections Shopping Essentials ePaper Puzzmo Newsletters Travel Business Ads Obituaries Classifieds Jobs HomeAtlantic CanadaNewsNova ScotiaHalifaxNova Scotia's new chief medical officer of health to take over from Dr. Robert Strang in JanuaryDr.
This article is an excerpt. To read the full content, visit the original source. PNI Atlantic News
Related articles
New N.S. chief medical officer of health named as Dr. Robert Strang to retire - CBC
Nova ScotiaDr. Jesse Kancir is taking over the job of Nova Scotia's chief medical officer of health in January, replacing Dr. Robert Strang who became a household name during the pandemic. Dr. Jesse Kancir to lead Nova Scotia's public health office in 2027Carolyn Ray · CBC News · Posted: Oct 14, 2026 3:46 PM EDT | Last Updated: October 14Listen to this articleEstimated 3 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Dr. Jesse Kancir knows it will take Nova Scotians some time to adjust to having a new leader at the public health office. (Alexandre Pirottin/Radio-Canada)There's a new face of public health in Nova Scotia. Dr. Jesse Kancir is taking over the job of chief medical officer of health in January, replacing Dr. Robert Strang, who became a household name during the COVID-19 pandemic but is now set to retire. "Like most Nova Scotians, I got to know Dr. Strang through the pandemic," Kancir said at a news conference held Wednesday to announce his promotion.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!